Yawei Hao

2.3k total citations · 1 hit paper
19 papers, 1.9k citations indexed

About

Yawei Hao is a scholar working on Cell Biology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Yawei Hao has authored 19 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cell Biology, 13 papers in Molecular Biology and 2 papers in Infectious Diseases. Recurrent topics in Yawei Hao's work include Hippo pathway signaling and YAP/TAZ (14 papers), Wnt/β-catenin signaling in development and cancer (6 papers) and Heat shock proteins research (4 papers). Yawei Hao is often cited by papers focused on Hippo pathway signaling and YAP/TAZ (14 papers), Wnt/β-catenin signaling in development and cancer (6 papers) and Heat shock proteins research (4 papers). Yawei Hao collaborates with scholars based in Canada, United States and Saudi Arabia. Yawei Hao's co-authors include Xiaolong Yang, Babak Rashidi, Kevin J. Cheung, Dulcie Lai, King Ching Ho, Helena J. Janse van Rensburg, Taha Azad, Alan Pater, Ling Min and Brooke Snetsinger and has published in prestigious journals such as Journal of Biological Chemistry, Nature Cell Biology and Cancer Research.

In The Last Decade

Yawei Hao

19 papers receiving 1.9k citations

Hit Papers

Tumor Suppressor LATS1 Is a Negative Regulator of Oncogen... 2007 2026 2013 2019 2007 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yawei Hao Canada 13 1.4k 1.2k 297 129 121 19 1.9k
Siew Wee Chan Singapore 20 2.1k 1.6× 1.6k 1.3× 315 1.1× 122 0.9× 87 0.7× 24 2.7k
Tackhoon Kim South Korea 15 593 0.4× 604 0.5× 190 0.6× 90 0.7× 63 0.5× 25 978
Takahisa Kuga Japan 21 399 0.3× 921 0.7× 255 0.9× 125 1.0× 83 0.7× 51 1.2k
Matthew K. Summers United States 22 711 0.5× 1.3k 1.1× 450 1.5× 149 1.2× 46 0.4× 39 1.6k
Steven D. Cappell United States 16 372 0.3× 1.0k 0.8× 433 1.5× 111 0.9× 71 0.6× 25 1.4k
Zhenye Yang China 16 769 0.6× 832 0.7× 221 0.7× 71 0.6× 62 0.5× 41 1.2k
Verónica Rodríguez-Bravo United States 15 620 0.5× 1.2k 1.0× 624 2.1× 288 2.2× 86 0.7× 27 1.7k
Joan Grindlay United Kingdom 11 621 0.5× 1.1k 0.9× 154 0.5× 128 1.0× 63 0.5× 12 1.4k
David Romano Ireland 15 544 0.4× 750 0.6× 217 0.7× 70 0.5× 41 0.3× 22 1.1k

Countries citing papers authored by Yawei Hao

Since Specialization
Citations

This map shows the geographic impact of Yawei Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yawei Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yawei Hao more than expected).

Fields of papers citing papers by Yawei Hao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yawei Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yawei Hao. The network helps show where Yawei Hao may publish in the future.

Co-authorship network of co-authors of Yawei Hao

This figure shows the co-authorship network connecting the top 25 collaborators of Yawei Hao. A scholar is included among the top collaborators of Yawei Hao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yawei Hao. Yawei Hao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Hao, Yawei, et al.. (2024). Identification of PTPN12 Phosphatase as a Novel Negative Regulator of Hippo Pathway Effectors YAP/TAZ in Breast Cancer. International Journal of Molecular Sciences. 25(7). 4064–4064. 2 indexed citations
2.
Wu, Liqing, et al.. (2023). Development of a New HiBiT Biosensor Monitoring Stability of YAP/TAZ Proteins in Cells. Chemosensors. 11(9). 492–492. 4 indexed citations
3.
Yang, Xiaolong, Lidong Liu, Yawei Hao, et al.. (2021). A Bioluminescent Biosensor for Quantifying the Interaction of SARS-CoV-2 and Its Receptor ACE2 in Cells and In Vitro. Viruses. 13(6). 1055–1055. 4 indexed citations
4.
Azad, Taha, Kazem Nouri, Helena J. Janse van Rensburg, et al.. (2019). A gain-of-functional screen identifies the Hippo pathway as a central mediator of receptor tyrosine kinases during tumorigenesis. Oncogene. 39(2). 334–355. 51 indexed citations
5.
Nouri, Kazem, Taha Azad, Ling Min, et al.. (2019). Identification of Celastrol as a Novel YAP-TEAD Inhibitor for Cancer Therapy by High Throughput Screening with Ultrasensitive YAP/TAZ–TEAD Biosensors. Cancers. 11(10). 1596–1596. 44 indexed citations
6.
Zhao, Yulei, Taha Azad, Elizabeth D. Lightbody, et al.. (2018). PI3K Positively Regulates YAP and TAZ in Mammary Tumorigenesis Through Multiple Signaling Pathways. Molecular Cancer Research. 16(6). 1046–1058. 56 indexed citations
7.
Rensburg, Helena J. Janse van, Taha Azad, Ling Min, et al.. (2018). The Hippo Pathway Component TAZ Promotes Immune Evasion in Human Cancer through PD-L1. Cancer Research. 78(6). 1457–1470. 244 indexed citations
8.
Rensburg, Helena J. Janse van, Dulcie Lai, Taha Azad, Yawei Hao, & Xiaolong Yang. (2018). TAZ enhances mammary cell proliferation in 3D culture through transcriptional regulation of IRS1. Cellular Signalling. 52. 12–22. 12 indexed citations
9.
Azad, Taha, Kazem Nouri, Helena J. Janse van Rensburg, Yawei Hao, & Xiaolong Yang. (2018). Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor (LATS) Biosensor. Journal of Visualized Experiments. 9 indexed citations
10.
Hao, Yawei, et al.. (2017). TAZ induces lung cancer stem cell properties and tumorigenesis by up-regulating ALDH1A1. Oncotarget. 8(24). 38426–38443. 32 indexed citations
11.
Zhao, Yulei, et al.. (2015). Hippo Component TAZ Functions as a Co-repressor and Negatively Regulates ΔNp63 Transcription through TEA Domain (TEAD) Transcription Factor. Journal of Biological Chemistry. 290(27). 16906–16917. 37 indexed citations
12.
Lai, Dulcie, King Ching Ho, Yawei Hao, & Xiaolong Yang. (2011). Taxol Resistance in Breast Cancer Cells Is Mediated by the Hippo Pathway Component TAZ and Its Downstream Transcriptional TargetsCyr61andCTGF. Cancer Research. 71(7). 2728–2738. 358 indexed citations
13.
Chow, Annabelle, Yawei Hao, & Xiaolong Yang. (2009). Molecular characterization of human homologs of yeast MOB1. International Journal of Cancer. 126(9). 2079–2089. 39 indexed citations
14.
Hao, Yawei, et al.. (2007). Tumor Suppressor LATS1 Is a Negative Regulator of Oncogene YAP. Journal of Biological Chemistry. 283(9). 5496–5509. 652 indexed citations breakdown →
15.
Yang, Xiaolong, et al.. (2004). LATS1 tumour suppressor affects cytokinesis by inhibiting LIMK1. Nature Cell Biology. 6(7). 609–617. 156 indexed citations
16.
Hao, Yawei, et al.. (2000). BAG-1 Promotes Apoptosis Induced by N-(4-hydroxyphenyl)retinamide in Human Cervical Carcinoma Cells. Experimental Cell Research. 256(2). 491–499. 27 indexed citations
17.
Yang, Xiaolong, Yawei Hao, Alex Ferenczy, Shou‐Ching Tang, & Alan Pater. (2000). Overexpression of Anti-apoptotic Gene BAG-1 in Human Cervical Cancer. Experimental Cell Research. 256(2). 583–583. 9 indexed citations
18.
Yang, Xiaolong, Yawei Hao, Alex Ferenczy, Shou‐Ching Tang, & Alan Pater. (1999). Overexpression of Anti-apoptotic Gene BAG-1 in Human Cervical Cancer. Experimental Cell Research. 247(1). 200–207. 45 indexed citations
19.
Yang, Xiaolong, Garry Chernenko, Yawei Hao, et al.. (1998). Human BAG-1/RAP46 protein is generated as four isoforms by alternative translation initiation and overexpressed in cancer cells. Oncogene. 17(8). 981–989. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026